COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,031 Articles (22,627 medRxiv, 8,404 bioRxiv)

Most recent first Previous |  Page 3009: Articles 30081-30090  | Next

Prevalence and Factors Associated with Depression and Anxiety of Hospitalized Patients with COVID-19
Dong, Y., Su, T., Jiao, P., Kong, X., Zheng, K., Tang, M., Kong, F., Zhou, J., Diao, L., Wu, S.
10.1101/2020.03.24.20043075 — Posted: 2020-03-30
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial
Chen, Z., Hu, J., Zhang, Z., Shan Jiang, S., Han, S., Yan, D., Zhuang, R., Hu, B., Zhang, Z.
10.1101/2020.03.22.20040758 — Posted: 2020-03-30 Discussion: Onsite | Offsite
Why estimating population-based case fatality rates during epidemics may be misleading
Böttcher, L., Xia, M., Chou, T.
10.1101/2020.03.26.20044693 — Posted: 2020-03-30
The comparative superiority of IgM-IgG antibody test to real-time reverse transcriptase PCR detection for SARS-CoV-2 infection diagnosis
Liu, R., Liu, X., Han, H., Shereen, M. A., Niu, Z., Li, D., Liu, F., Wu, K., Luo, Z., Zhu, C.
10.1101/2020.03.28.20045765 — Posted: 2020-03-30 Discussion: Onsite
Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients
Zhang, N., Gong, Y., Meng, F., Bi, Y., Yang, P., Wang, F.
10.1101/2020.03.28.20043059 — Posted: 2020-03-30 Discussion: Onsite
SARS-CoV-2 detection using digital PCR for COVID-19 diagnosis, treatment monitoring and criteria for discharge
Lu, R., Wang, J., Li, M., Wang, Y., Dong, J., Cai, W.
10.1101/2020.03.24.20042689 — Posted: 2020-03-30 Discussion: Onsite | Offsite
Global, Regional and National Incidence and Case-fatality rate of Novel Coronavirus (COVID-19) across 154 countries and territories: A systematic assessment of cases reported from January to March 16, 2020
Bhagavathula, A. S., Rahmani, J., Aldhaleei, W. A., Rovetta, A.
10.1101/2020.03.26.20044743 — Posted: 2020-03-30
Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation
Gao, T., Hu, M., Zhang, X., Li, H., Zhu, L., Liu, H., Dong, Q., Zhang, Z., Wang, Z., Hu, Y., Fu, Y., Jin, Y., Li, K., Zhao, S., Xiao, Y., Luo, S., Li, L., Zhao, L., Liu, J., Zhao, H., Liu, Y., Yang, W., Peng, J., Chen, X., Li, P., Liu, Y., Xie, Y., Song, J., Zhang, L., Ma, Q., Bian, X., Chen, W., Liu, X., Mao, Q., Cao, C.
10.1101/2020.03.29.20041962 — Posted: 2020-03-30 Discussion: Onsite
Climate effect on COVID-19 spread rate: an online surveillance tool
Caspi, G., Shalit, U., Kristensen, S. L., Aronson, D., Caspi, L., Rossenberg, O., Shina, A., Caspi, O.
10.1101/2020.03.26.20044727 — Posted: 2020-03-30
Persistent SARS-CoV-2 presence is companied with defects in adaptive immune system in non-severe COVID-19 patients
Liu, B., Han, J., Cheng, X., Yu, L., Zhang, L., Wang, W., Ni, L., Wei, C., Huang, Y., Cheng, Z.
10.1101/2020.03.26.20044768 — Posted: 2020-03-30 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).